Related Experiment Video
Updated: Oct 2, 2026
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
[Liver transplantation for hepatocellular carcinoma: a report of 8 patients]
1Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
Objective:
To evaluate the feasibility of liver transplantation as a treatment for hepatocellular carcinoma (HCC).
Methods:
From July 1995 to October 1998, eight liver cancer patients with cirrhosis underwent liver transplantation in Queen Mary Hospital. The liver grafts were obtained from 6 brainstem dead donors and 2 living donors. Five patients had known HCC and 3 had incidental tumor identified in the explanted liver. TNM staging: stage II (5 cases), stage III (2 cases) and stage IV a (1 case). After liver transplantation, the patients were followed up prospectively for a median of 36 months. Except for one patient who had preoperative chemotherapy, no anticancer treatment was given before and after transplantation.
Results:
Three patients had acute rejection, 5 developed complication in early post transplantation. All were treated promptly and improved. One patient died one year after operation from septicemia. The recurrence-free survival rates of one and three years were 100% and 83.3%, respectively.
Conclusions:
Liver transplantation is a feasible method for treatment of HCC in selected patients. Living donor liver transplantation can overcome the problems of donor shortage and tumor growth while waiting for liver transplantation.